Any current/future capex/capital investment/strategic investment?

NOCIL Limited has announced a Rs.250 crore capex at the Dahej facility. This capex is for a brownfield new plant, not merely a debottlenecking project. The expansion aims to increase capacity by approximately 20%. Timeline for commissioning: plant expected to be ready by September 2026 (30 months from announcement). Post-commissioning trials and approvals may take an additional 3-4 months. Business from this new plant is likely to start contributing from Q4 FY '27. The company is also actively exploring inorganic opportunities to leverage its strengths in chemistry and related capabilities. On

Future growth expectations in sales/revenue/volumes?

Current capacity utilization is at 70%, with an intention to grow volumes sequentially quarter-over-quarter starting from a base index of 140 (Q1 FY'20 = 100). No specific full-year guidance for FY '25 is given; focus is on consistent quarterly volume growth. Export volumes exhibiting double-digit year-on-year growth, driven by long-term customer engagements and expanding international presence. Domestic demand remains robust, supported by stable replacement volumes in tire industry and some recovery in latex-related business. A new brownfield capex of Rs. 250 crores at Dahej to expand

Future growth expectations in earnings/operating earnings/profits/EPS?

Management aims for sequential quarter-over-quarter volume growth starting from a base index of 140, targeting continuous improvement but avoids specific numerical guidance. Operating leverage is expected to improve with volume growth, though exact EBITDA uplifts (e.g., 3-4% from 10% volume growth) are not quantified due to dependence on product mix. Volume growth benefits anticipated from new customer wins, especially in specialty products, and expansion in international markets including South America and North America. Capex of Rs.250 crores at Dahej for a brownfield expansion is expe

NOCIL LtdQ2 FY25Chemicals & Petrochemicals

NOCIL Ltd Q2 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹145.35P/E: 34.9Market Cap: ₹2.4K CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 4

Margin

Category 2

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 4

Current capacity utilization is at 70%, with an intention to grow volumes sequentially quarter-over-quarter starting from a base index of 140 (Q1 FY'20 = 100).
No specific full-year guidance for FY '25 is given; focus is on consistent quarterly volume growth.
Export volumes exhibiting double-digit year-on-year growth, driven by long-term customer engagements and expanding international presence.
Domestic demand remains robust, supported by stable replacement volumes in tire industry and some recovery in latex-related business.
A new brownfield capex of Rs. 250 crores at Dahej to expand capacity by 20%, expected commissioning by September 2026 (FY '27 Q4 for volume contribution).
Continuous efforts toward better margin, specialized products development, and portfolio diversification ongoing, focusing on margin improvement rather than commodity volume.
Volume growth in H1 FY '25 was about 9%, with expectations for improvement in H2 FY '25 as logistic challenges ease.

Margin guidance

Category 2

Management aims for sequential quarter-over-quarter volume growth starting from a base index of 140, targeting continuous improvement but avoids specific numerical guidance.
Operating leverage is expected to improve with volume growth, though exact EBITDA uplifts (e.g., 3-4% from 10% volume growth) are not quantified due to dependence on product mix.
Volume growth benefits anticipated from new customer wins, especially in specialty products, and expansion in international markets including South America and North America.
Capex of Rs.250 crores at Dahej for a brownfield expansion is expected to support growth.
Gross profit margins are expected to improve marginally (~1%), driven by operational efficiencies despite intense pricing competition.
Export volumes are recovering with double-digit growth, aiding revenue growth amidst global challenges.
Management remains positive on growth opportunities while acknowledging competitive and external market uncertainties.

See what NOCIL Ltd management said on margin guidance — free account, 30 seconds.

Fundraise plans

- There is no mention of any current or planned fundraising through debt or equity in the provided transcript. - The company is focused on organic growth, including a Rs.250 crore brownfield capex project at the Dahej facility. - The management is actively exploring inorganic growth opportunities but has not indicated any timeline or plan for raising funds via debt or equity. - Cash balances on the balance sheet are significantly higher, suggesting a strong liquidity position. - Any decisions regarding fundraising would depend on strategic considerations and market conditions, which are yet to be finalized. Hence, as of the October 29, 2024 call, NOCIL Limited has not announced or indicated plans for new debt or equity fundraising.

Order book

The transcript does not explicitly mention the current or expected order book or pending orders in quantified terms. However, relevant points reflecting order status and outlook include: - The company is witnessing positive volume development despite logistics challenges. - There are ongoing approvals from multiple customers and sites on a quarterly basis, indicating a healthy pipeline. - NOCIL expects continued volume growth in the second half of FY'25 supported by new customer wins and strategic engagements. - The company's export business is showing strong double-digit volume growth, implying steady order inflows internationally. - Long-term relationships and strategic engagements provide reliability and help mitigate competitive pressures. - The management remains optimistic about volume growth driven by replacement demand and expanding specialty product sales. Overall, while no exact order book figures are disclosed, the commentary suggests a positive and growing order pipeline both domestically and internationally.

See what NOCIL Ltd management said on order book — free account, 30 seconds.

Capex plans

Yes

NOCIL Limited has announced a Rs.250 crore capex at the Dahej facility.
This capex is for a brownfield new plant, not merely a debottlenecking project.
The expansion aims to increase capacity by approximately 20%.
Timeline for commissioning: plant expected to be ready by September 2026 (30 months from announcement).
Post-commissioning trials and approvals may take an additional 3-4 months.
Business from this new plant is likely to start contributing from Q4 FY '27.
The company is also actively exploring inorganic opportunities to leverage its strengths in chemistry and related capabilities.
Ongoing focus on improving operational efficiencies, eco-friendly practices, and leveraging technology as part of strategic growth objectives.

Track NOCIL Ltd — get its next earnings analysis in your feed

How does NOCIL Ltd rank vs peers in Chemicals & Petrochemicals?

Pro feature

ThisNOCIL Ltd

Rev 4Mar 2

See where NOCIL Ltd sits in Chemicals & PetrochemicalsSee which companies these are, and every other name in the sector.Open rankings

How does NOCIL Ltd rank in Chemicals & Petrochemicals?

Compare NOCIL Ltd against every Chemicals & Petrochemicals company (Q2 FY25) on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

What NOCIL Ltd's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

Alufluoride Ltd (Q1 FY27)
Revenue from operations for Q1 FY27 was ₹26.6 crore, down 39% YoY (Page 6, 7, 8). Key investor presentation takeaways from Alufluoride Ltd's Q1 FY27 investor pr
POCL Enterprises Ltd (Q1 FY27)
466.03 crores (Page 12, 17, 11) . Key investor presentation takeaways from POCL Enterprises Ltd's Q1 FY27 investor presentation — and how it ranks against secto
Deepak Nitrite Ltd (Q2 FY27)
Q2 FY27 total revenue: ₹3,091 crore, up 61% YoY (Page 1, 4, 5, 6, 10, 11) . Key investor presentation takeaways from Deepak Nitrite Ltd's Q2 FY27 investor prese
Privi Speciality Chemicals Ltd (Q2 FY27)
19,239.47 lakhs (approximately 33.9% growth). Key results statement takeaways from Privi Speciality Chemicals Ltd's Q2 FY27 results statement — and how it ranks

Compare:vs Solar Industries vs Pidilite Inds.vs SRF Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →